These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1389 related items for PubMed ID: 27476114
21. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q. Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145 [Abstract] [Full Text] [Related]
22. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study. Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, Ditzel HJ. Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649 [Abstract] [Full Text] [Related]
23. Serum microRNAs as diagnostic markers of endometriosis: a comprehensive array-based analysis. Cosar E, Mamillapalli R, Ersoy GS, Cho S, Seifer B, Taylor HS. Fertil Steril; 2016 Aug; 106(2):402-9. PubMed ID: 27179784 [Abstract] [Full Text] [Related]
24. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer. Shi GL, Chen Y, Sun Y, Yin YJ, Song CX. Clin Lab; 2017 Jan 01; 63(1):133-140. PubMed ID: 28164492 [Abstract] [Full Text] [Related]
25. Differential expression levels of plasma microRNA in Hashimoto's disease. Zhao L, Zhou X, Shan X, Qi LW, Wang T, Zhu J, Zhu D, Huang Z, Zhang L, Zhang H, Yin Y, Wang Z, Zhu W, Cheng W, Jiang L. Gene; 2018 Feb 05; 642():152-158. PubMed ID: 29054761 [Abstract] [Full Text] [Related]
26. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma. Guan Y, Chen L, Bao Y, Pang C, Cui R, Li G, Liu J, Wang Y. Int J Clin Exp Pathol; 2015 Feb 05; 8(1):727-34. PubMed ID: 25755767 [Abstract] [Full Text] [Related]
27. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study. Marchesi F, Regazzo G, Palombi F, Terrenato I, Sacconi A, Spagnuolo M, Donzelli S, Marino M, Ercolani C, Di Benedetto A, Blandino G, Ciliberto G, Mengarelli A, Rizzo MG. J Exp Clin Cancer Res; 2018 May 02; 37(1):95. PubMed ID: 29716630 [Abstract] [Full Text] [Related]
28. Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma. D'Angelo E, Fassan M, Maretto I, Pucciarelli S, Zanon C, Digito M, Rugge M, Nitti D, Agostini M. Oncotarget; 2016 May 10; 7(19):28647-57. PubMed ID: 27081702 [Abstract] [Full Text] [Related]
29. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer. Zhang J, Raju GS, Chang DW, Lin SH, Chen Z, Wu X. Cancer; 2018 Feb 15; 124(4):785-796. PubMed ID: 29112225 [Abstract] [Full Text] [Related]
30. Downregulation of plasma miR-124 expression is a predictive biomarker for prognosis of glioma. Wang LQ, Sun W, Wang Y, Li D, Hu AM. Eur Rev Med Pharmacol Sci; 2019 Jan 15; 23(1):271-276. PubMed ID: 30657585 [Abstract] [Full Text] [Related]
31. Circulating microRNA-137 is a potential biomarker for human glioblastoma. Li HY, Li YM, Li Y, Shi XW, Chen H. Eur Rev Med Pharmacol Sci; 2016 Sep 15; 20(17):3599-604. PubMed ID: 27649660 [Abstract] [Full Text] [Related]
32. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance. Yang L, Xu Q, Xie H, Gu G, Jiang J. Clin Transl Oncol; 2016 Aug 15; 18(8):841-7. PubMed ID: 26586116 [Abstract] [Full Text] [Related]
33. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma. Pang C, Guan Y, Zhao K, Chen L, Bao Y, Cui R, Li G, Wang Y. Int J Clin Exp Pathol; 2015 Aug 15; 8(5):4943-52. PubMed ID: 26191187 [Abstract] [Full Text] [Related]
34. Potential Diagnostic and Prognostic Value of Plasma Circulating MicroRNA-182 in Human Glioma. Xiao Y, Zhang L, Song Z, Guo C, Zhu J, Li Z, Zhu S. Med Sci Monit; 2016 Mar 15; 22():855-62. PubMed ID: 26978735 [Abstract] [Full Text] [Related]
35. Methylation of the miR-126 gene associated with glioma progression. Cui H, Mu Y, Yu L, Xi YG, Matthiesen R, Su X, Sun W. Fam Cancer; 2016 Apr 15; 15(2):317-24. PubMed ID: 26463235 [Abstract] [Full Text] [Related]
36. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Zhang Y, Sui J, Shen X, Li C, Yao W, Hong W, Peng H, Pu Y, Yin L, Liang G. Oncol Rep; 2017 Jun 15; 37(6):3543-3553. PubMed ID: 28498428 [Abstract] [Full Text] [Related]
37. A miRNA signature for defining aggressive phenotype and prognosis in gliomas. Barbano R, Palumbo O, Pasculli B, Galasso M, Volinia S, D'Angelo V, Icolaro N, Coco M, Dimitri L, Graziano P, Copetti M, Valori VM, Maiello E, Carella M, Fazio VM, Parrella P. PLoS One; 2014 Jun 15; 9(10):e108950. PubMed ID: 25279461 [Abstract] [Full Text] [Related]
38. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Zekri AN, Youssef AS, El-Desouky ED, Ahmed OS, Lotfy MM, Nassar AA, Bahnassey AA. Tumour Biol; 2016 Sep 15; 37(9):12273-12286. PubMed ID: 27271989 [Abstract] [Full Text] [Related]